T1	PROC 56 79	terapias personalizadas
T2	DISO 97 130	carcinoma de páncreas metastásico
T3	PROC 145 162	análisis genético
#1	AnnotatorNotes T3	C0679560; Genetic screening method; Laboratory Procedure
T4	DISO 167 172	tumor
#2	AnnotatorNotes T4	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T5	DISO 214 244	Cáncer de páncreas metastásico
T6	DISO 340 378	adenocarcinoma metastásico de páncreas
T7	ANAT 370 378	páncreas
#3	AnnotatorNotes T7	C0030274; Pancreas; Body Part, Organ, or Organ Component | C1278931; Entire pancreas; Body Part, Organ, or Organ Component
T8	DISO 400 409	tumorales
#4	AnnotatorNotes T8	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T9	DISO 452 470	Enfermedad medible
#5	AnnotatorNotes T9	C1513041; Measurable Disease; Disease or Syndrome
T10	PROC 525 537	radioterapia
#6	AnnotatorNotes T10	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T11	PROC 539 546	cirugía
#7	AnnotatorNotes T11	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T12	PROC 548 561	quimioterapia
#8	AnnotatorNotes T12	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T13	PROC 574 602	tratamiento en investigación
#9	AnnotatorNotes T13	C0949266; Therapies, Investigational; Therapeutic or Preventive Procedure
T14	PROC 439 447	biopsiar
#10	AnnotatorNotes T14	C0005558; Biopsy; Diagnostic Procedure
T15	PROC 611 622	tratamiento
#11	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	DISO 629 651	enfermedad metastásica
#12	AnnotatorNotes T16	C2939420; Metastatic Neoplasm; Neoplastic Process
T17	PROC 696 726	quimioterapia de primera línea
#13	AnnotatorNotes T17	C2045825; chemotherapeutics regimen first line of treatment; Therapeutic or Preventive Procedure
T18	PROC 742 764	radioterapia paliativa
#14	AnnotatorNotes T18	C0475092; Palliative course of radiotherapy; Therapeutic or Preventive Procedure
T19	DISO 774 790	metástasis óseas
#15	AnnotatorNotes T19	C0153690; Secondary malignant neoplasm of bone; Neoplastic Process
T20	PROC 795 804	Hemograma
#16	AnnotatorNotes T20	C0009555; Complete Blood Count; Laboratory Procedure
T21	PROC 870 884	aleatorización
#17	AnnotatorNotes T21	C0034656; Randomization; Research Activity
T22	PROC 888 920	Recuento absoluto de neutrófilos
#18	AnnotatorNotes T22	C0948762; Absolute neutrophil count; Laboratory Procedure
T23	PROC 922 925	RAN
#19	AnnotatorNotes T23	C0948762; Absolute neutrophil count; Laboratory Procedure
T24	PROC 947 956	Plaquetas
#20	AnnotatorNotes T24	C0032181; Platelet Count measurement; Laboratory Procedure
T25	ANAT 1037 1046	sanguínea
#21	AnnotatorNotes T25	C0005767; Blood; Body Substance
T26	PROC 1026 1046	Bioquímica sanguínea
T27	PROC 1086 1090	SGOT
T28	DISO 1180 1200	metástasis hepáticas
#22	AnnotatorNotes T28	C0494165; Secondary malignant neoplasm of liver; Neoplastic Process
T29	PROC 1235 1252	Bilirrubina total
#23	AnnotatorNotes T29	C0201913; Bilirubin, total measurement; Laboratory Procedure
T30	CHEM 1269 1277	Albúmina
#24	AnnotatorNotes T30	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T31	CHEM 1298 1308	Creatinina
#25	AnnotatorNotes T31	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T32	ANAT 1309 1315	sérica
#26	AnnotatorNotes T32	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T33	PROC 1456 1479	métodos anticonceptivos
#27	AnnotatorNotes T33	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T34	DISO 1539 1560	Metástasis cerebrales
#28	AnnotatorNotes T34	C0220650; Metastatic malignant neoplasm to brain; Neoplastic Process | C0555278; Cerebral metastasis; Neoplastic Process
T35	PROC 1595 1603	tratadas
#29	AnnotatorNotes T35	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	DISO 1676 1686	enfermedad
#30	AnnotatorNotes T36	C0012634; Disease; Disease or Syndrome
T37	DISO 1723 1729	cáncer
#31	AnnotatorNotes T37	C0006826; Malignant Neoplasms; Neoplastic Process
T38	DISO 1756 1765;1789 1816	Infección bacteriana, viral o fúngica
T39	PROC 1831 1852	tratamiento sistémico
T40	PROC 1902 1919	biopsia del tumor
T41	DISO 1924 1933	Infección
#32	AnnotatorNotes T41	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T42	DISO 1959 1970	hepatitis B
#33	AnnotatorNotes T42	C0019163; Hepatitis B; Disease or Syndrome
T43	DISO 1974 1985	hepatitis C
#34	AnnotatorNotes T43	C0019196; Hepatitis C; Disease or Syndrome
T44	ANAT 2002 2016	cardiovascular
#35	AnnotatorNotes T44	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T45	PROC 2053 2096	implantación reciente de un stent coronario
T46	ANAT 2087 2096	coronario
#36	AnnotatorNotes T46	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T47	DISO 2099 2119	infarto de miocardio
#37	AnnotatorNotes T47	C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T48	ANAT 2210 2217	órganos
#38	AnnotatorNotes T48	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T49	DISO 2221 2245	trastornos psiquiátricos
#39	AnnotatorNotes T49	C0004936; Mental disorders; Mental or Behavioral Dysfunction
T50	DISO 1995 2016	riesgo cardiovascular
#40	AnnotatorNotes T50	C4324389; Cardiovascular Risk; Finding
T51	PROC 2426 2440	procedimientos
#41	AnnotatorNotes T51	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T52	PROC 2516 2533	biopsia del tumor
T53	PROC 2563 2575	intervención
#42	AnnotatorNotes T53	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T54	ANAT 110 118	páncreas
#43	AnnotatorNotes T54	C0030274; Pancreas; Body Part, Organ, or Organ Component | C1278931; Entire pancreas; Body Part, Organ, or Organ Component
T55	ANAT 224 232	páncreas
#44	AnnotatorNotes T55	C0030274; Pancreas; Body Part, Organ, or Organ Component | C1278931; Entire pancreas; Body Part, Organ, or Organ Component
T56	DISO 410 422	metastásicos
#45	AnnotatorNotes T56	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T57	ANAT 785 790	óseas
#46	AnnotatorNotes T57	C0262950; Skeletal bone; Body Part, Organ, or Organ Component | C0391978; Bone Tissue; Tissue
T58	ANAT 909 920	neutrófilos
#47	AnnotatorNotes T58	C0027950; neutrophil; Cell
T59	PROC 993 1004	Hemoglobina
#48	AnnotatorNotes T59	C0518015; Hemoglobin measurement; Laboratory Procedure
T60	PROC 1006 1008	Hb
#49	AnnotatorNotes T60	C0518015; Hemoglobin measurement; Laboratory Procedure
T61	PROC 1081 1084	AST
#50	AnnotatorNotes T61	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T62	PROC 1093 1096	ALT
#51	AnnotatorNotes T62	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T63	PROC 1098 1102	SGPT
#52	AnnotatorNotes T63	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T64	ANAT 1191 1200	hepáticas
#53	AnnotatorNotes T64	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T65	CHEM 1235 1246	Bilirrubina
#54	AnnotatorNotes T65	C0005437; Bilirubin; Biologically Active Substance · Organic Chemical
T66	PROC 1269 1283	Albúmina total
T67	PROC 1298 1315	Creatinina sérica
#55	AnnotatorNotes T67	C0201976; Creatinine measurement, serum (procedure); Laboratory Procedure
T68	PROC 1350 1386	Consentimiento informado por escrito
#56	AnnotatorNotes T68	C0811741; Obtain informed written consent; Health Care Activity
T69	ANAT 1550 1560	cerebrales
#57	AnnotatorNotes T69	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T71	DISO 1914 1919	tumor
#58	AnnotatorNotes T71	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T72	DISO 1954 1957	VIH
#59	AnnotatorNotes T72	C0458074; Human immunodeficiency virus (HIV) status; Finding
T73	ANAT 2110 2119	miocardio
#60	AnnotatorNotes T73	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T74	DISO 2528 2533	tumor
#61	AnnotatorNotes T74	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T75	Date 12 16	2015
T76	LIVB 83 92	pacientes
#62	AnnotatorNotes T76	C0030705; Patients; Patient or Disabled Group
T77	Age 279 295	mayor de 18 años
T78	Spec_cue 423 435	susceptibles
T79	LIVB 491 500	pacientes
#63	AnnotatorNotes T79	C0030705; Patients; Patient or Disabled Group
T80	Neg_cue 501 503	no
T81	Duration 847 857	<= 14 días
T84	LIVB 1396 1420	pacientes en edad fértil
#64	AnnotatorNotes T84	C4324275; Woman of childbearing potential; Population Group
T85	Age 1409 1420	edad fértil
T88	Duration 1644 1660	al menos 3 meses
T89	Duration 1733 1751	los últimos 5 años
T91	LIVB 1789 1799	bacteriana
#65	AnnotatorNotes T91	C0004611; Bacteria; Bacterium
T92	LIVB 1801 1806	viral
#66	AnnotatorNotes T92	C0042776; Virus; Virus
T93	LIVB 1809 1816	fúngica
#67	AnnotatorNotes T93	C0016832; Fungi; Fungus
T97	Date 2066 2074	reciente
T98	DEVI 2081 2096	stent coronario
#68	AnnotatorNotes T98	C0687568; Coronary artery stent; Medical Device
T99	Date 2123 2136	el pasado año
T102	LIVB 2336 2381	Paciente embarazada o en periodo de lactancia
#69	AnnotatorNotes T102	C0033011; Pregnant Women; Population Group + C4316174; Patients who are breastfeeding; Patient or Disabled Group
T103	LIVB 2387 2396	Pacientes
#70	AnnotatorNotes T103	C0030705; Patients; Patient or Disabled Group
T104	Neg_cue 2397 2409	incapaces de
T105	LIVB 2458 2467	pacientes
#71	AnnotatorNotes T105	C0030705; Patients; Patient or Disabled Group
T107	GENE 154 162	genético
#72	AnnotatorNotes T107	C0017337; Genes; Gene or Genome
T110	PHYS 2345 2355	embarazada
#73	AnnotatorNotes T110	C0032961; Pregnancy; Organism Function
T82	PHYS 2372 2381	lactancia
#74	AnnotatorNotes T82	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T70	PROC 299 336	Confirmación histológica o citológica
#75	AnnotatorNotes T70	C1305671; Cytology procedure; Laboratory Procedure + C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T14 Speculated
A2	Assertion T10 Negated
A3	Assertion T11 Negated
A4	Assertion T12 Negated
A5	Assertion T13 Negated
A8	Assertion T51 Negated
A9	Status T41 History_of
A10	Assertion T40 Contraindicated
A11	Status T37 History_of
A12	Status T10 History_of
A13	Status T11 History_of
A14	Status T12 History_of
A15	Status T13 History_of
A16	Status T35 History_of
A17	Status T45 History_of
A18	Status T47 History_of
#76	AnnotatorNotes T97	C0332185; Recent; Temporal Concept
T83	Neg_cue 1774 1776	no
T86	Quantifier_or_Qualifier 1777 1787	controlada
A6	Assertion T86 Negated
T87	Neg_cue 2035 2037	no
T90	Quantifier_or_Qualifier 2038 2046	limitado
A7	Assertion T90 Negated
T94	Spec_cue 2258 2265	podrían
T95	Observation 2266 2306	comprometer la seguridad o la integridad
A19	Assertion T95 Speculated
R1	Negation Arg1:T80 Arg2:T10	
R2	Negation Arg1:T80 Arg2:T11	
R3	Negation Arg1:T80 Arg2:T12	
R4	Negation Arg1:T80 Arg2:T13	
R5	Negation Arg1:T83 Arg2:T86	
R6	Negation Arg1:T87 Arg2:T90	
R7	Speculation Arg1:T94 Arg2:T95	
R8	Negation Arg1:T104 Arg2:T51	
R9	Experiences Arg1:T76 Arg2:T1	
R10	Location_of Arg1:T54 Arg2:T2	
R11	Location_of Arg1:T55 Arg2:T5	
R12	Location_of Arg1:T7 Arg2:T6	
#77	AnnotatorNotes T2	C0861727; Pancreatic adenocarcinoma metastatic; Neoplastic Process (?)
#78	AnnotatorNotes T5	C0346976; Secondary malignant neoplasm of pancreas; Neoplastic Process (?)
R14	Experiences Arg1:T76 Arg2:T2	
R15	Before Arg1:T3 Arg2:T1	
R16	Experiences Arg1:T76 Arg2:T4	
T96	LIVB 185 191	Avatar
#79	AnnotatorNotes T96	C0599779; Animal Model; Animal
T100	Quantifier_or_Qualifier 383 392	Uno o más
T101	Observation 393 409	sitios tumorales
#80	AnnotatorNotes T101	C0475445; Tumor site; Finding
R18	Has_Quantifier_or_Qualifier Arg1:T101 Arg2:T100	
R19	Has_Quantifier_or_Qualifier Arg1:T101 Arg2:T56	
R20	Speculation Arg1:T78 Arg2:T14	
T106	Quantifier_or_Qualifier 473 482	evaluable
#81	AnnotatorNotes T106	C5575332; Evaluable; Qualitative Concept
R24	Experiences Arg1:T79 Arg2:T10	
R25	Experiences Arg1:T79 Arg2:T11	
R26	Experiences Arg1:T79 Arg2:T12	
R27	Experiences Arg1:T79 Arg2:T13	
R28	Experiences Arg1:T79 Arg2:T15	
R29	Experiences Arg1:T79 Arg2:T16	
T108	Quantifier_or_Qualifier 675 692	3 primeros ciclos
R30	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T108	
R31	Experiences Arg1:T79 Arg2:T17	
R32	Location_of Arg1:T57 Arg2:T19	
T109	CONC 817 835	inicio del estudio
#82	AnnotatorNotes T109	C4684789; Study Start; Temporal Concept | C2349982; Study start time; Temporal Concept
R33	Overlap Arg1:T20 Arg2:T109	
R34	Overlap Arg1:T20 Arg2:T81	
R35	Before Arg1:T20 Arg2:T21	
T111	Result_or_Value 927 943	>= 1,5 x 109 / l
R36	Has_Result_or_Value Arg1:T22 Arg2:T111	
R37	Has_Result_or_Value Arg1:T23 Arg2:T111	
T112	Quantifier_or_Qualifier 805 813	adecuado
#83	AnnotatorNotes T112	C0205411; Adequate; Qualitative Concept
R38	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T112	
T113	Result_or_Value 957 989	>= 100.000 / mm3 (100 × 109 / L)
R39	Has_Result_or_Value Arg1:T24 Arg2:T113	
T114	Result_or_Value 1010 1021	>= 9 g / dl
R40	Has_Result_or_Value Arg1:T59 Arg2:T114	
R41	Has_Result_or_Value Arg1:T60 Arg2:T114	
R42	Location_of Arg1:T25 Arg2:T26	
T115	Quantifier_or_Qualifier 1047 1055	adecuada
#84	AnnotatorNotes T115	C0205411; Adequate; Qualitative Concept
R43	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T115	
T116	CONC 1059 1077	inicio del estudio
#85	AnnotatorNotes T116	C4684789; Study Start; Temporal Concept | C2349982; Study start time; Temporal Concept
R44	Overlap Arg1:T26 Arg2:T116	
T117	Result_or_Value 1104 1148	<= 2.5 × límite superior de normalidad (LSN)
R45	Has_Result_or_Value Arg1:T61 Arg2:T117	
R46	Has_Result_or_Value Arg1:T27 Arg2:T117	
R47	Has_Result_or_Value Arg1:T62 Arg2:T117	
R48	Has_Result_or_Value Arg1:T63 Arg2:T117	
#86	AnnotatorNotes T26	C0005774; Blood Chemical Analysis; Laboratory Procedure | C0430037; blood chemistry - general (non-specific); Laboratory Procedure
R49	Location_of Arg1:T64 Arg2:T28	
T118	Result_or_Value 1222 1232	<= 5 × LSN
R50	Overlap Arg1:T28 Arg2:T118	
R51	Has_Result_or_Value Arg1:T61 Arg2:T118	
R52	Has_Result_or_Value Arg1:T27 Arg2:T118	
R53	Has_Result_or_Value Arg1:T62 Arg2:T118	
R54	Has_Result_or_Value Arg1:T63 Arg2:T118	
#87	AnnotatorNotes T27	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T119	Result_or_Value 1253 1265	<= 1,5 x LSN
R55	Has_Result_or_Value Arg1:T29 Arg2:T119	
T120	Result_or_Value 1284 1295	>= 0,75 LSN
R56	Has_Result_or_Value Arg1:T66 Arg2:T120	
R57	Location_of Arg1:T32 Arg2:T67	
T121	Result_or_Value 1316 1328	<= 1,5 x LSN
R58	Has_Result_or_Value Arg1:T67 Arg2:T121	
T122	Result_or_Value 1340 1345	0 - 1
T123	CONC 1332 1336	ECOG
#88	AnnotatorNotes T123	C1520224; ECOG performance status; Intellectual Product
R59	Has_Result_or_Value Arg1:T123 Arg2:T122	
R60	Has_Age Arg1:T84 Arg2:T85	
T124	Observation 1427 1443	estar de acuerdo
#89	AnnotatorNotes T124	C0600109; Willing; Finding (?)
R61	Overlap Arg1:T124 Arg2:T33	
T125	Quantifier_or_Qualifier 1480 1489	adecuados
#90	AnnotatorNotes T125	C0205411; Adequate; Qualitative Concept
R62	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T125	
T126	PROC 1501 1508	estudio
#91	AnnotatorNotes T126	C0008976; Clinical Trials; Research Activity
R63	Overlap Arg1:T33 Arg2:T126	
R64	Location_of Arg1:T69 Arg2:T34	
T127	Quantifier_or_Qualifier 1624 1635	controladas
R66	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T127	
R67	Has_Duration_or_Interval Arg1:T127 Arg2:T88	
T128	Quantifier_or_Qualifier 1687 1706	localmente avanzada
R65	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T128	
T129	Quantifier_or_Qualifier 1665 1675	Únicamente
R68	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T129	
R69	Overlap Arg1:T37 Arg2:T89	
#92	AnnotatorNotes T38	C4748213; Bacterial, viral, and fungal infections; Finding
R70	Causes Arg1:T91 Arg2:T38	
R71	Causes Arg1:T92 Arg2:T38	
R72	Causes Arg1:T93 Arg2:T38	
R73	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T86	
#93	AnnotatorNotes T39	C1515119; Systemic Therapy; Therapeutic or Preventive Procedure
T130	Quantifier_or_Qualifier 1766 1772	activa
#94	AnnotatorNotes T130	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R75	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T130	
T131	Quantifier_or_Qualifier 1943 1949	activa
#95	AnnotatorNotes T131	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R76	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T131	
R77	Has_Quantifier_or_Qualifier Arg1:T72 Arg2:T131	
R78	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T131	
R79	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T131	
A20	Status T72 History_of
A21	Status T42 History_of
A22	Status T43 History_of
R80	Location_of Arg1:T44 Arg2:T50	
R81	Has_Quantifier_or_Qualifier Arg1:T50 Arg2:T90	
R82	Overlap Arg1:T45 Arg2:T97	
R83	Used_for Arg1:T98 Arg2:T45	
R84	Location_of Arg1:T46 Arg2:T45	
T132	Quantifier_or_Qualifier 1990 1994	Alto
#96	AnnotatorNotes T132	C0205250; High; Qualitative Concept
R85	Has_Quantifier_or_Qualifier Arg1:T50 Arg2:T132	
R86	Overlap Arg1:T47 Arg2:T99	
R87	Location_of Arg1:T73 Arg2:T47	
T133	Observation 2141 2159	Factores de riesgo
#97	AnnotatorNotes T133	C0035648; risk factors; Finding
T134	Quantifier_or_Qualifier 2160 2166	graves
#98	AnnotatorNotes T134	C1547227; Severe - Severity of Illness Code; Intellectual Product
R88	Has_Quantifier_or_Qualifier Arg1:T133 Arg2:T134	
T135	Quantifier_or_Qualifier 2246 2252	graves
#99	AnnotatorNotes T135	C1547227; Severe - Severity of Illness Code; Intellectual Product
R89	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T135	
R90	Before Arg1:T133 Arg2:T95	
R91	Before Arg1:T49 Arg2:T95	
R92	Experiences Arg1:T102 Arg2:T110	
R93	Experiences Arg1:T102 Arg2:T82	
R94	Experiences Arg1:T103 Arg2:T51	
T136	Observation 2474 2490	estar de acuerdo
#100	AnnotatorNotes T136	C0600109; Willing; Finding (?)
R97	Experiences Arg1:T105 Arg2:T74	
R98	Experiences Arg1:T105 Arg2:T53	
R99	Before Arg1:T52 Arg2:T53	
T137	CONC 178 191	modelo Avatar
R100	Before Arg1:T137 Arg2:T1	
R101	Location_of Arg1:T54 Arg2:T4	
#101	AnnotatorNotes T129	C0205171; Singular; Quantitative Concept
R13	Overlap Arg1:T136 Arg2:T52	
R17	Experiences Arg1:T105 Arg2:T52	
#102	AnnotatorNotes T90	C0439801; Limited (extensiveness); Functional Concept
#103	AnnotatorNotes T6	C0861727; Pancreatic adenocarcinoma metastatic; Neoplastic Process
A23	Experiencer T76 Patient
A24	Experiencer T79 Patient
A25	Assertion T28 Hypothetical
A26	Experiencer T84 Patient
A27	Experiencer T102 Patient
A28	Experiencer T103 Patient
A29	Experiencer T105 Patient
A30	Assertion T53 Hypothetical
